Checkpoint Therapeutics Inc Takeover Cash Assented Line
Sell:314.31pBuy:314.31p
No change
Prices delayed by at least 15 minutes
- This stock can be held in a
Stocks and Shares ISASell:314.31p
Buy:314.31p
Change:No change
No changePrices delayed by at least 15 minutes
Sell:314.31p
Buy:314.31p
Change:No change
No changePrices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 30 May 2025 | Christian BechonDirector | Sell Regular sell transaction (market) | 141,718 | $4.10 | $581,043.80 | 0 |
| 30 May 2025 | William Garrett GrayCFO | Sell Regular sell transaction (market) | 1,446,322 | $4.10 | $5,929,920.20 | 0 |
| 30 May 2025 | Neil HerskowitzDirector | Sell Regular sell transaction (market) | 147,007 | $4.10 | $602,728.70 | 0 |
| 30 May 2025 | James F III OlivieroPresident/CEO | Sell Regular sell transaction (market) | 3,759,929 | $4.10 | $15,415,708.90 | 0 |
| 30 May 2025 | Lindsay Allan RosenwaldDirector | Sell Regular sell transaction (market) | 207,007 | $4.10 | $848,728.70 | 0 |
| 30 May 2025 | Barry M SalzmanDirector | Sell Regular sell transaction (market) | 147,007 | $4.10 | $602,728.70 | 0 |
| 30 May 2025 | Michael Sean WeissDirector | Sell Regular sell transaction (market) | 187,007 | $4.10 | $766,728.70 | 0 |
| 30 May 2025 | FORTRESS BIOTECH INCParent Company | Sell Regular sell transaction (market) | 6,122,249 | $4.10 | $25,101,220.90 | 0 |
| 30 May 2025 | FORTRESS BIOTECH INCParent Company | Sell Regular sell transaction (market) | 700,000 | $4.10 | $2,870,000.00 | 0 |
| 30 May 2025 | Amit SharmaDirector | Sell Regular sell transaction (market) | 94,246 | $4.10 | $386,408.60 | 0 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 30 May 2025 | FORTRESS BIOTECH INCParent Company | Sell Regular sell transaction (market) | 6,122,249 | $4.10 | $25,101,220.90 | 0 |
| 30 May 2025 | James F III OlivieroPresident/CEO | Sell Regular sell transaction (market) | 3,759,929 | $4.10 | $15,415,708.90 | 0 |
| 30 May 2025 | William Garrett GrayCFO | Sell Regular sell transaction (market) | 1,446,322 | $4.10 | $5,929,920.20 | 0 |
| 30 May 2025 | FORTRESS BIOTECH INCParent Company | Sell Regular sell transaction (market) | 700,000 | $4.10 | $2,870,000.00 | 0 |
| 18 December 2024 | James F III OlivieroPresident/CEO | Sell Tax related | 602,167 | $3.87 | $2,330,386.29 | 3,414,813 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.